SE0301663D0 - Analysmetod för infusionsläkemedel - Google Patents

Analysmetod för infusionsläkemedel

Info

Publication number
SE0301663D0
SE0301663D0 SE0301663A SE0301663A SE0301663D0 SE 0301663 D0 SE0301663 D0 SE 0301663D0 SE 0301663 A SE0301663 A SE 0301663A SE 0301663 A SE0301663 A SE 0301663A SE 0301663 D0 SE0301663 D0 SE 0301663D0
Authority
SE
Sweden
Prior art keywords
analysis
infusion
drugs
infusion drugs
administered
Prior art date
Application number
SE0301663A
Other languages
English (en)
Inventor
Bo Lennernaes
Original Assignee
Oncolog Medical Qa Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolog Medical Qa Ab filed Critical Oncolog Medical Qa Ab
Priority to SE0301663A priority Critical patent/SE0301663D0/sv
Publication of SE0301663D0 publication Critical patent/SE0301663D0/sv
Priority to JP2006517024A priority patent/JP2006527381A/ja
Priority to US10/559,186 priority patent/US20060160238A1/en
Priority to EP04736476.5A priority patent/EP1634060B1/en
Priority to PCT/SE2004/000900 priority patent/WO2004109262A1/en
Priority to US12/345,236 priority patent/US20090177407A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65—Raman scattering
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N2021/6417—Spectrofluorimetric devices
    • G01N2021/6423—Spectral mapping, video display
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
    • G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
    • G01N24/10—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using electron paramagnetic resonance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE0301663A 2003-06-10 2003-06-10 Analysmetod för infusionsläkemedel SE0301663D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0301663A SE0301663D0 (sv) 2003-06-10 2003-06-10 Analysmetod för infusionsläkemedel
JP2006517024A JP2006527381A (ja) 2003-06-10 2004-06-09 注射あるいは点滴用薬物の分析、確認および品質保証のための方法と装置
US10/559,186 US20060160238A1 (en) 2003-06-10 2004-06-09 Method and device for analysis, verification and quality assurance of drugs for injection or infusion
EP04736476.5A EP1634060B1 (en) 2003-06-10 2004-06-09 Method and device for analysis, verification and quality assurance of drugs for infusion
PCT/SE2004/000900 WO2004109262A1 (en) 2003-06-10 2004-06-09 Method and device for analysis, verification and quality assurance of drugs for injection or infusion
US12/345,236 US20090177407A1 (en) 2003-06-10 2008-12-29 Method and device for analysis, verification and quality assurance of drugs for injection or infusion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301663A SE0301663D0 (sv) 2003-06-10 2003-06-10 Analysmetod för infusionsläkemedel

Publications (1)

Publication Number Publication Date
SE0301663D0 true SE0301663D0 (sv) 2003-06-10

Family

ID=29212399

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301663A SE0301663D0 (sv) 2003-06-10 2003-06-10 Analysmetod för infusionsläkemedel

Country Status (5)

Country Link
US (2) US20060160238A1 (sv)
EP (1) EP1634060B1 (sv)
JP (1) JP2006527381A (sv)
SE (1) SE0301663D0 (sv)
WO (1) WO2004109262A1 (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101244B2 (en) * 2004-06-09 2012-01-24 Smithkline Beecham Corporation Apparatus and method for producing or processing a product or sample
US20060002594A1 (en) * 2004-06-09 2006-01-05 Clarke Allan J Method for producing a pharmaceutical product
TWI428271B (zh) * 2004-06-09 2014-03-01 Smithkline Beecham Corp 生產藥物之裝置及方法
WO2006024650A2 (en) * 2004-09-02 2006-03-09 Novo Nordisk A/S Medical device adapted for detection of drug condition
US20100312384A1 (en) * 2007-11-29 2010-12-09 Searete LLC, limited liability corporation of the state of Delaware Programmed dispensing of consumable compositions
EP2250472A2 (en) * 2008-03-04 2010-11-17 Verrana, Llc Spectrometric methods and apparatus
US11244745B2 (en) 2010-01-22 2022-02-08 Deka Products Limited Partnership Computer-implemented method, system, and apparatus for electronic patient care
WO2012138236A1 (en) 2011-04-06 2012-10-11 Krouse Donal Paul Spectroscopic analyser
US9308051B2 (en) 2011-11-15 2016-04-12 Smiths Medical Asd, Inc. Illuminated tubing set
US9308323B2 (en) * 2011-11-15 2016-04-12 Smiths Medical Asd, Inc. Systems and methods for illuminated medical tubing detection and management indicating a characteristic of at least one infusion pump
JP6269983B2 (ja) 2012-06-19 2018-01-31 クライン メディカル リミテッド 分光分析
US20140092376A1 (en) * 2012-10-01 2014-04-03 Momentive Performance Materials, Inc. Container and method for in-line analysis of protein compositions
US9665689B2 (en) 2013-05-17 2017-05-30 Viavi Solutions Inc. Medication assurance system and method
US10034978B2 (en) 2015-01-27 2018-07-31 Pharmacolog I Uppsala Ab Method and system for dose rate regulation in drug infusion treatment
EP3211551B1 (en) * 2016-01-20 2023-12-20 Zyno Medical, Llc Apparatus and method for delivery-contemporaneous medicine verification
US20170255760A1 (en) * 2016-03-07 2017-09-07 Zyno Medical, Llc Automatic Drug Dispensing System with Medicine Verification
CA3064572A1 (en) * 2017-05-22 2018-11-29 Valisure Llc Methods for validating medication

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053632A (en) * 1971-06-11 1977-10-11 Astra Lakemedel Aktiebolag Compounds of spiro-amine type and methods for their use
JPS53143296A (en) * 1977-05-19 1978-12-13 Daiichi Seiyaku Co Judgeing method for anomaly of solution in container
SU913255A1 (ru) * 1980-07-10 1982-03-15 Vnii Farmatsii Inst Geokhimii Способ определения пирогенности инъекционных растворов 1 _ . ·
US4853521A (en) * 1987-12-28 1989-08-01 Claeys Ronald W System for verifying and recording drug administration to a patient
US5956144A (en) * 1992-09-03 1999-09-21 Micro Research, Inc. Method and apparatus for use of polarized light vectors in identifying and evaluating constituent compounds in a specimen
US5531697A (en) * 1994-04-15 1996-07-02 Sims Deltec, Inc. Systems and methods for cassette identification for drug pumps
US5491344A (en) * 1993-12-01 1996-02-13 Tufts University Method and system for examining the composition of a fluid or solid sample using fluorescence and/or absorption spectroscopy
US5510621A (en) * 1994-10-03 1996-04-23 Optical Solutions, Inc. Apparatus and method for measuring components in a bag
JPH09184761A (ja) * 1995-12-29 1997-07-15 Horiba Ltd ２つのスペクトルの一致度算出方法
DE19713249A1 (de) * 1997-03-29 1998-10-01 Dornier Gmbh Multifunktionales Reagenzgefäß für die chemische, biochemische und immunologische Analytik
US6070761A (en) * 1997-08-22 2000-06-06 Deka Products Limited Partnership Vial loading method and apparatus for intelligent admixture and delivery of intravenous drugs
US6111639A (en) 1998-05-06 2000-08-29 Reduto; Lawrence A. Method and apparatus for countering adverse drug events
WO1999058954A1 (en) * 1998-05-13 1999-11-18 Bayer Corporation Optical spectroscopy sample cell
JP2000084074A (ja) * 1998-09-10 2000-03-28 Shinten Sangyo Kk 気泡センサ
US6410255B1 (en) * 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
US6947848B2 (en) * 2000-08-07 2005-09-20 Cooper Union For The Advancement Of Science And Art System and method for identifying unknown compounds using spectra pattern recognition
JP3860118B2 (ja) * 2001-01-26 2006-12-20 スミスクライン ビーチャム コーポレーション 治療薬のｉｎｖｉｔｒｏ分析のためのシステムおよび方法
US6771369B2 (en) * 2002-03-12 2004-08-03 Analytical Spectral Devices, Inc. System and method for pharmacy validation and inspection
US6847899B2 (en) * 2002-04-26 2005-01-25 Dean Allgeyer, M.D., Inc. Device and method for qualitative and quantitative determination of intravenous fluid components
WO2004072868A1 (en) * 2003-02-10 2004-08-26 Verication, L.L.C. Database and method of use for authenticity verification of pharmaceuticals
US7256888B2 (en) * 2003-11-07 2007-08-14 Cardial Health 303, Inc. Fluid verification system and method for infusions

Also Published As

Publication number Publication date
JP2006527381A (ja) 2006-11-30
US20060160238A1 (en) 2006-07-20
WO2004109262A1 (en) 2004-12-16
US20090177407A1 (en) 2009-07-09
EP1634060B1 (en) 2013-12-25
EP1634060A1 (en) 2006-03-15

Similar Documents

Publication Publication Date Title
SE0301663D0 (sv) Analysmetod för infusionsläkemedel
MX344727B (es) Formulaciones liquidas de anticuerpos anti-tnf-alfa de alta concentracion mejoradas.
CY1117940T1 (el) Πρωτεϊνες συνδεσης αντιγονου προς προπρωτεϊνη κονβερτασης σουμπτιλισινης κεχιν τυπου 9(pcsk9)
MEP31508A (en) Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
CY1113231T1 (el) Απαραβιαστες φαρμακοτεχνικες μορφες δοσολογιας απο του στοματος περιλαμβανουσες ενα οπιουχο αναλγητικο
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
EA201070757A1 (ru) Режим дозирования инъекционных препаратов эфиров палиперидона длительного действия
SG155054A1 (en) Human anti- neutralizing antibodies as selective pathway inhibitors
ATE311910T1 (de) Identification from ampoule
EA201001695A1 (ru) Применение эпотилона d для лечения заболеваний, связанных с тау-белком
NO20065227L (no) Menoklonale antistoff mot hepatocytt vekstfaktor
DK1539166T3 (da) Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme
NO20055173L (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
EA200971053A1 (ru) Способы лечения кожных язв
MX2019007779A (es) Metodo cosmetico para el tratamiento o reduccion de paniculopatia edemato-fibroesclerotica (pefe).
ME00226B (me) Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
ATE513562T1 (de) Nicht-spezifische immunstimulierende mittel
DK2043637T3 (da) Fremgangsmåder og medikamenter til administrering af ibuprofen
DE602006012761D1 (de) Verfahren zur Identifizierung von Medikamenten, vor Verabreichung
DK1869185T3 (da) Konjugat med P21-protein til kræftbehandling
WO2006138589A3 (en) Opioid receptor ligands
EA200401462A1 (ru) Однокамерная система осмотически регулируемой доставки лекарственного средства
NO20075508L (no) Stannsoporfinpreparater og administrering
ATE548038T1 (de) Behandlung von arzneiresistenten tumoren
ATE454144T1 (de) Behandlung von malignen neoplasien